{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T19:16:33Z","timestamp":1721848593918},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"48","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,21]]},"DOI":"10.1093\/eurheartj\/ehab624","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T03:08:23Z","timestamp":1631156903000},"page":"4915-4918","source":"Crossref","is-referenced-by-count":6,"title":["Intravenous iron supplementation: novel anti-remodelling therapy for patients with heart failure?"],"prefix":"10.1093","volume":"42","author":[{"given":"Ewa A","family":"Jankowska","sequence":"first","affiliation":[{"name":"Institute of Heart Diseases, Wroclaw Medical Institute, and University Hospital in Wroclaw , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[{"name":"Institute of Heart Diseases, Wroclaw Medical Institute, and University Hospital in Wroclaw , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"2022102516563746400_ehab624-B1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","article-title":"Iron deficiency","volume":"397","author":"Pasricha","year":"2021","journal-title":"Lancet"},{"key":"2022102516563746400_ehab624-B2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"key":"2022102516563746400_ehab624-B3","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","article-title":"The burden of iron deficiency in heart failure: therapeutic approach","volume":"71","author":"Rocha","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102516563746400_ehab624-B4","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","article-title":"Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure","volume":"35","author":"Jankowska","year":"2014","journal-title":"Eur Heart J"},{"key":"2022102516563746400_ehab624-B5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"key":"2022102516563746400_ehab624-B6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/eurheartj\/ehs377","article-title":"Iron status in patients with chronic heart failure","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"key":"2022102516563746400_ehab624-B7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska","year":"2011","journal-title":"J Card Fail"},{"key":"2022102516563746400_ehab624-B8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijcard.2014.03.169","article-title":"Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study","volume":"174","author":"Enjuanes","year":"2014","journal-title":"Int J Cardiol"},{"key":"2022102516563746400_ehab624-B9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2022102516563746400_ehab624-B10","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2022102516563746400_ehab624-B11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2022102516563746400_ehab624-B12","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"2022102516563746400_ehab624-B13","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab234","article-title":"The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study","author":"Jankowska","year":"2021","journal-title":"Eur Heart J"},{"key":"2022102516563746400_ehab624-B14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/jcsm.12314","article-title":"Iron deficiency as energetic insult to skeletal muscle in chronic diseases","volume":"9","author":"Dziegala","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2022102516563746400_ehab624-B15","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab411","article-title":"The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy\u2014the IRON-CRT trial","author":"Martens","year":"2021","journal-title":"Eur Heart J"},{"key":"2022102516563746400_ehab624-B16","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ehf2.12675","article-title":"The effect of iron deficiency on cardiac resynchronization therapy: results from the RIDE-CRT Study","volume":"7","author":"Lacour","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2022102516563746400_ehab624-B17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2016.07.280","article-title":"Iron deficiency in heart failure: impact on response to cardiac resynchronization therapy","volume":"222","author":"Bojarczuk","year":"2016","journal-title":"Int J Cardiol"},{"key":"2022102516563746400_ehab624-B18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/eurjhf\/hft099","article-title":"Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial","volume":"15","author":"Filippatos","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2022102516563746400_ehab624-B19","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/CIRCULATIONAHA.118.038516","article-title":"Effect of iron isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency","volume":"139","author":"Charles-Edwards","year":"2019","journal-title":"Circulation"},{"key":"2022102516563746400_ehab624-B20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/CS20040278","article-title":"Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration","volume":"109","author":"Dong","year":"2005","journal-title":"Clin Sci (Lond)"},{"key":"2022102516563746400_ehab624-B21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000177592","article-title":"Iron deficiency in growing male rats: a cause of development of cardiomyopathy","volume":"34","author":"Petering","year":"1990","journal-title":"Ann Nutr Metab"},{"key":"2022102516563746400_ehab624-B22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3181\/00379727-218-44306","article-title":"Dietary iron deficiency results in cardiac eccentric hypertrophy in rats","volume":"218","author":"Medeiros","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"key":"2022102516563746400_ehab624-B23","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ejhf.1154","article-title":"Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function","volume":"20","author":"Hoes","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2022102516563746400_ehab624-B24","first-page":"362","article-title":"Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure","volume":"38","author":"Haddad","year":"2017","journal-title":"Eur Heart J"},{"key":"2022102516563746400_ehab624-B25","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.RES.39.5.744","article-title":"The effects of iron deficiency on the respiratory function and cytochrome content of rat heart mitochondria","volume":"39","author":"Blayney","year":"1976","journal-title":"Circ Res"},{"key":"2022102516563746400_ehab624-B26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.celrep.2015.09.023","article-title":"Lethal cardiomyopathy in mice lacking transferrin receptor in the heart","volume":"13","author":"Xu","year":"2015","journal-title":"Cell Rep"},{"key":"2022102516563746400_ehab624-B27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ejhf.640","article-title":"Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis","volume":"19","author":"Melenovsky","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2022102516563746400_ehab624-B28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2011.08.006","article-title":"Myocardial iron homeostasis in advanced chronic heart failure patients","volume":"159","author":"Leszek","year":"2012","journal-title":"Int J Cardiol"},{"key":"2022102516563746400_ehab624-B29","first-page":"e014254","article-title":"A; Myocardial-IRON Investigators. Noninvasive imaging estimation of myocardial iron repletion following administration of intravenous iron: the myocardial-IRON Trial. J Am Heart Assoc","volume":"9","author":"N\u00fa\u00f1ez","year":"2020","journal-title":"Com\u00edn-Colet J, Bay\u00e9s-Gen\u00eds"},{"key":"2022102516563746400_ehab624-B30","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/ejhf.1781","article-title":"Cardiac iron concentration in relation to systemic iron status and disease severity in non-ischaemic heart failure with reduced ejection fraction","volume":"22","author":"Hirsch","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022102516563746400_ehab624-B31","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3390\/cells10040818","article-title":"Primary human cardiomyocytes and cardiofibroblasts treated with sera from myocarditis patients exhibit an increased iron demand and complex changes in the gene expression","volume":"10","author":"Kobak","year":"2021","journal-title":"Cells"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/48\/4915\/46628575\/ehab624.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/48\/4915\/46628575\/ehab624.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T18:06:01Z","timestamp":1666721161000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/48\/4915\/6370026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":31,"journal-issue":{"issue":"48","published-online":{"date-parts":[[2021,9,14]]},"published-print":{"date-parts":[[2021,12,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab624","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,21]]},"published":{"date-parts":[[2021,9,14]]}}}